VITASPRING BIOMEDICAL CO. LTD. (OTC:VSBC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on January 23, 2026.
The Healthcare company reported Q0 revenue of .
VITASPRING BIOMEDICAL CO. LTD.'s stock currently trades at $1.00 with a market capitalization of $207.0M.